JMP Securities lowered the firm’s price target on Ibotta (IBTA) to $85 from $111 and keeps an Outperform rating on the shares. Ibotta ...

JMP Securities lowered the firm’s price target on OptimizeRx (OPRX) to $8 from $16 and keeps an Outperform rating on the shares.

Fintel reports that on November 13, 2024, JMP Securities downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...

Fintel reports that on November 7, 2024, JMP Securities downgraded their outlook for MacroGenics (NasdaqGS:MGNX) from Market ...

Reddit's ability to ensure more human conversation has broadened its appeal and helped it become a place for people not ...

JMP Securities raised the firm’s price target on Expensify (EXFY) to $3.25 from $2.50 and keeps a Market Perform rating on the shares after “mostly better than expected” Q3 earnings.

JMP Securities raised the firm’s price target on OneMain (OMF) to $62 from $60 and keeps an Outperform rating on the shares. Credit dynamics are showing signs of improvement even with the ...

On Friday, Snap Inc (SNAP) stock saw a modest uptick, ending the day at $12.53 which represents a slight increase of $0.37 or 3.04% from the prior close of $12.16. The stock opened at $12.25 and ...

Investing.com -- Snap shares rose 2% in premarket trading Wednesday after JMP Securities analysts upgraded the stock from Market Perform to Outperform and set a price target of $17. The firm’s ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

Reddit (NYSE:RDDT – Get Free Report) had its price objective lifted by equities researchers at JMP Securities from $84.00 to ...

The U.S. presidential election is an important short-term catalyst for Coinbase and the wider industry, and could lead to ...